- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
SEBI imposes fine on Biocon's regulatory affair officer for insider trading
Mumbai: In a major setback to Biocon Ltd., markets regulator Securities and Exchange Board of India (SEBI)on Friday levied a fine on an employee attached to the drugmaker for violating insider trading norms while dealing in the scrip of the firm.
As per a recent PTI report, the employee, V. Singh (noticee), general manager regulatory affair of Biocon at the time of investigation and also a designated person, is facing a fine of Rs 3 lakh for violating provisions of Prohibition of Insider Trading (PIT) norms.
An investigation carried out by the regulator found that Singh, who held 9,550 shares of the company, acquired through exercise of employee stock option plan (ESOP), sold 3,550 shares between May 2018 to September 2018 without seeking pre-clearance from the compliance officer.
"The noticee by not obtaining pre-clearance from the compliance officer of Biocon for the transactions in question has violated the provisions of PIT Regulations," Sebi stated.
Read also: Biocon Employee Penalized By SEBI For Violating Insider Trading Norms
In addition, Singh also delayed making requisite disclosures.
In terms of PIT Regulations, every promoter, employee and director of every company shall disclose to the company the number of securities acquired or disposed of within two trading days of the transaction if the value of the securities traded crosses a certain threshold.
In the instant case, Singh's transactions exceeded the value of Rs 10 lakh on two occasions and were required to be disclosed within two days, but she failed to do so.
Accordingly, Sebi imposed a consolidated fine of Rs 3 lakh on Singh for both the violations -- not obtaining pre-clearance and making delayed disclosures.
"Taking into consideration all the facts and circumstances of the case including the aforesaid 15J factors and exercising the powers conferred upon me under section 15I of the SEBI Act read with Rule 5 of the Adjudication Rules, I hereby impose a consolidated monetary penalty of ₹ 3,00,000/- (Rupees Three Lakh Only) on the Noticee in totality for both the violations i.e. not obtaining preclearance as well as making delayed disclosures which attracts section 15HB and 15A (b) of the SEBI Act, respectively. In my view, the said penalty is commensurate with the violations committed by the Noticee in this case," the order stated.
To access the official order by SEB, click on the link below-
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751